Skip to Main Content
Prescriber's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Drug Information
  4. Charts

Charts

  • Disease-Related Charts (575)
  • Practice-Related Charts (210)
541 - 555 of 654 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Redosing Oral Medications After Vomiting September 2009
Chart: Redosing of Selected Medications After Vomiting September 2009
Commentary: New Drug: Onglyza (Saxagliptin) September 2009
Other: Sample Collaborative Practice Agreement August 2009
Chart: Sulfonylurea Dose Comparison August 2009
Chart: Collaborative Drug Therapy Management (CDTM) August 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Chart: Follow-on Drugs: Therapeutic Benefit or Economic Burden? July 2009
Commentary: Nuvigil (Armodafinil) July 2009
Commentary: Sunscreens: Achieving Optimal Protection June 2009
Guideline: Pharmacology and Management of the Vitamin K Antagonists (ACCP, 8th edition, Summary) June 2009
Commentary: Use of Low-Dose Vitamin K Supplements to Stabilize INR June 2009
Commentary: Tablet Splitting May 2009
Commentary: FDA to Halt Marketing of Certain Unapproved Prescription Opioids May 2009
Commentary: Drug Shortages April 2009
  • « Prev
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved